CBRE vs FBLG · P/E 43, rev $40.55B vs $24.0M cap
CBRE Group Inc Class A (CBRE) versus FibroBiologics, Inc. Common Stock (FBLG) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
FibroBiologics, Inc. Common Stock (FBLG) is a biotechnology company listed on US.
Latest reported CBRE revenue for 2025-12-31 was $40.55B. Net income was $1.16B. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
FBLG does not have a complete income-statement cache yet.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. FBLG currently screens at market cap $24.0M.
Not investment advice. Open the CBRE and FBLG stock pages for the full models.
Not investment advice.